Lenskart vs Titan Eyewear: 7 factors decide who wins India's Rs 30,000 crore market (resurfacing a late-September listing update)
Resurfacing Lenskart's late-September post-listing performance at Rs 390 (vs Rs 402 issue price), the stock is benchmarked against Titan EyeCare across store reach, cost, and margins. Lenskart leans on 9.3M H1 eye tests, 46% first-time users, in-house manufacturing (69.2% product margin, 35-40% cost edge) and next-day delivery in 58 cities; Titan counters with omnichannel prescription-led demand and trained optometrists.
What happened
Lenskart's market debut sparks comparison with Titan EyeCare across seven factors: store reach, models, cost structure, and margins. Lenskart bets on eye
Key facts
- listed at Rs 390
- issue price Rs 402
- declined 2.23% over month
- Titan +0.99% month, +10.85% year
- market $9.2 billion
- Rs 30,000 crore market
- Titan share <12%
- 9.3M eye tests H1 FY26
- 46% first-time users
- 203 net new stores
- 431 cities
- 871 EyeCare stores
- 500+ remote testing stores
- next-day in 58 cities
- product margin 69.2%
- 35%-40% cost advantage
- 4M frames H1
Why this matters
With 46% first-time users and 9.3M H1 eye tests, Lenskart is expanding the category rather than just taking share, making optometry talent, manufacturing capacity, and tier-2 store footprint the key assets to acquire or partner around.
What to watch
- Lenskart quarterly same-store-sales and net new store adds
- Product margin trajectory vs the 69.2% baseline
- Titan EyeCare revenue growth and market-share moves past 12%
- Discounting intensity / promotional spend on both platforms
- Lenskart share price recovery above Rs 402 issue price
- New entrant capex or D2C funding announcements in eyewear
- Lenskart accelerates store rollout beyond 58 cities and expands in-house manufacturing capacity to defend cost edge
- Lenskart pushes eye-test volume (9.3M H1) as top-of-funnel to raise conversion and lifetime value
- Titan expands optometrist-led premium and progressive-lens SKUs to widen ARPU gap
- Both invest in omnichannel and same/next-day delivery parity
- Lenskart signals path to profitability to arrest sub-issue-price stock slide